We Need to Build Post COVID Sick Care System Immunity

We Need to Build Post COVID Sick Care System Immunity

We Need to Build Post COVID Sick Care System Immunity

Patients, sick care workers and organizations in our dysfunctional sick care system of systems were left vulnerable to the pandemic, something many experts predicted, but whose warnings went unheeded.

But, eventually, the parts of the biomedical industrial and educational complex will either die or recover to some degree and need weeks, if not months, of post-discharge care and rehabilitation to rebuild their immunity as things gradually come back to some semblance of the new normal.

Public policy experts are already planning for how cities should recover.

Here are some places where we need post acute care discharge care pathways now to accelerate healing and recovery and build immunity to prevent post discharge readmission when we see the next wave of disease:

  1. Hospital and non-hospital care facilities, like ERs, urgent care centers, pharmacies, and , yes, pot shops and liquor stores that have been designated essential industries.
  2. Rural health facilities.
  3. Higher ed,graduate schools, health professional graduate schools and residency training programs.
  4. Biopharma , medtech and medical supply chains and innovation.
  5. The clinical trial value chain.
  6. Biomedical and clinical innovation and entrepreneurship clusters.
  7. Nursing homes and long term care facilities.
  8. Federally run care facilities like the VA, the Indian Health Service and the Public Health Service.
  9. Ambulatory surgery and office based surgery centers.
  10. Post graduate health related programs in business schools, schools of public health and health administration programs.

It is likely that the demand for services will dry up for a while and it won't be business as usual after the Coronapocalypse. High school students will reconsider college. Patients will reconsider going to brick and mortar facilities. Medical schools will have to reinvent themselves. Retiring doctors will rewire doing remote, online work and many younger docs will rethink long clinical careers. And, the entire system might finally figure out now to stop wasting close to a trillion dollars in sick care spending every year.

The economy is in the ICU, not just thousands of patients. Long-term morbidity, in the forms of cognitive, physical and psychological impairments, has significant consequences for survivors of critical illness and for their caregivers. ICU patients may develop PTSD anchored to their critical illness experience, with ICU-related PTSD incidence rates of 10%. Using ICU diaries during a critical illness may minimize the occurrence of future ICU-related PTSD. The same could happen to those on the front lines of the pandemic when they come back home.

Like the virus itself, the highest mortality rates in the biomedical industrial and educational complex will be in those with compromised immune systems that can't fight the forces of change to their models and revenue streams. Those that survive, unfortunately, will not develop antibodies to the next wave of illness, that most likely will happen, it they do not fortify their defenses as they recover. The challenge is that, except in a national emergency, corporate immune systems are very effective at snuffing our innovation, not the pervasive systemic and operational effects of the new corona virus.

Arlen Meyers, MD, MBA is the President and CEO of the Society of Physician Entrepreneurs on Twitter@ArlenMD and Facebook.

Share this article

Leave your comments

Post comment as a guest

terms and condition.
  • Noel C

    Hospitals ain't ready for this revolution

  • Scott Andrews

    Many people will be battling with their metal health while in isolation.

  • Tim Mccormick

    I can't take it anymore! Hopefully they will learn from the past.

Share this article

Arlen Meyers, MD, MBA

Former Contributor

Arlen Meyers, MD, MBA is a professor emeritus of otolaryngology, dentistry, and engineering at the University of Colorado School of Medicine and the Colorado School of Public Health and President and CEO of the Society of Physician Entrepreneurs at www.sopenet.org. He has created several medical device and digital health companies. His primary research centers around biomedical and health innovation and entrepreneurship and life science technology commercialization. He consults for and speaks to companies, governments, colleges and universities around the world who need his expertise and contacts in the areas of bio entrepreneurship, bioscience, healthcare, healthcare IT, medical tourism -- nationally and internationally, new product development, product design, and financing new ventures. He is a former Harvard-Macy fellow and In 2010, he completed a Fulbright at Kings Business, the commercialization office of technology transfer at Kings College in London. He recently published "Building the Case for Biotechnology." "Optical Detection of Cancer", and " The Life Science Innovation Roadmap". He is also an associate editor of the Journal of Commercial Biotechnology and Technology Transfer and Entrepreneurship and Editor-in-Chief of Medscape. In addition, He is a faculty member at the University of Colorado Denver Graduate School where he teaches Biomedical Entrepreneurship and is an iCorps participant, trainer and industry mentor. He is the Chief Medical Officer at www.bridgehealth.com and www.cliexa.com and Chairman of the Board at GlobalMindED at www.globalminded.org, a non-profit at risk student success network. He is honored to be named by Modern Healthcare as one of the 50 Most Influential Physician Executives of 2011 and nominated in 2012 and Best Doctors 2013.

Cookies user prefences
We use cookies to ensure you to get the best experience on our website. If you decline the use of cookies, this website may not function as expected.
Accept all
Decline all
Read more
Tools used to analyze the data to measure the effectiveness of a website and to understand how it works.
Google Analytics